Omniscan (Gadodiamide)

Gadodiamide, the active ingredient in Omniscan, is a contrast media presented as a 0.5 ml/mL solution for intravenous use. It enhances magnetic resonance imaging (MRI) by improving the visibility of vascular structures and lesions. GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Omniscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Omniscan is used in magnetic MRI procedures that require enhanced vascular and tissue contrast. It helps: - Central nervous system imaging: improves the detection of lesions and tumours in the brain and spine. - Cardiovascular imaging : provides enhanced visual assessment of cardiac chambers and vascular patency by the contrast enhancement of blood flow. - Whole‑body whole‑body imaging : facilitates the identification of metastatic disease and systemic lesions ac‑ ac ac "); -  ");  \